ADIM
MRUS

Alpha DNA Investment Management’s Merus MRUS Stock Holding History

Alpha DNA Investment Management’s Portfolio MRUS Stock Details MRUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-25,380
Closed -$598K – 216
2023
Q3 		$598K Sell
25,380
-3,437
-12% -$83.4K 0.24% 86
2023
Q2 		$759K Buy
+28,817
New +$631K 0.25% 119

Other funds holding MRUS

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
SC
Samlyn Capital New York $5.86B AUM 36.3% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Alpha DNA Investment Management's MRUS Position: Q4 2023 in Review

Alpha DNA Investment Management sold out of Merus (MRUS) in Q4 2023, closing a stake of 25,380 shares — an estimated $598K sold.

Alpha DNA Investment Management first reported a position in MRUS in Q2 2023 and held it in 2 quarters. The position peaked at $759K in Q2 2023. 131 funds tracked by Wall St. Rank hold MRUS as of Q4 2023.

  • Alpha DNA Investment Management reported no remaining Merus position as of Q4 2023 after selling out during the quarter.
  • Alpha DNA Investment Management sold 25,380 Merus shares in Q4 2023, an estimated $598K.
  • Alpha DNA Investment Management first reported a position in Merus in Q2 2023 and held it in 2 quarters.
  • Alpha DNA Investment Management's Merus position peaked at $759K in Q2 2023.
  • 131 funds tracked by Wall St. Rank held Merus as of Q4 2023.

Based on Alpha DNA Investment Management's 13F filing for Q4 2023, filed 12 Feb 2024.